TW270112B - Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates - Google Patents

Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Info

Publication number
TW270112B
TW270112B TW83106290A TW83106290A TW270112B TW 270112 B TW270112 B TW 270112B TW 83106290 A TW83106290 A TW 83106290A TW 83106290 A TW83106290 A TW 83106290A TW 270112 B TW270112 B TW 270112B
Authority
TW
Taiwan
Prior art keywords
novel
production process
compounds capable
lowering blood
novel compounds
Prior art date
Application number
TW83106290A
Other languages
Chinese (zh)
Inventor
Huey-Bor Hwang
Arng Lii
Jinn-Tsair Fann
Original Assignee
Syn Tech Chem & Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn Tech Chem & Pharm Co Ltd filed Critical Syn Tech Chem & Pharm Co Ltd
Priority to TW83106290A priority Critical patent/TW270112B/en
Application granted granted Critical
Publication of TW270112B publication Critical patent/TW270112B/en

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A compound of the following formula (I) (see claim 1) in which R is hydroxyl, C1 to C6 alkoxy, phenylthio; R1 and R2 separately is C1 to C4 alkyl; R3 is hydrogen, hydroxyl, C1 to C6 alkoxy, C1 to C5 alkylamimeoxy, 3-methoxy pyridyl or (see claim 1) R3', R4, R5 separately is hydrogen or C1 to C4 alkyl; R6 and R7 separately is C1 to C6 alkyl and is located on the 2nd carbon or 5th carbon of the phenyl group; however when R is hydroxyl or C1 to C6 alkoxy, R1 is methyl, R2 is methyl and R3 is hydrogen or hydroxyl, at least one of R4 and R5 shall be selected from C1 to C4 alkyl.
TW83106290A 1994-07-12 1994-07-12 Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates TW270112B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW83106290A TW270112B (en) 1994-07-12 1994-07-12 Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW83106290A TW270112B (en) 1994-07-12 1994-07-12 Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Publications (1)

Publication Number Publication Date
TW270112B true TW270112B (en) 1996-02-11

Family

ID=51396966

Family Applications (1)

Application Number Title Priority Date Filing Date
TW83106290A TW270112B (en) 1994-07-12 1994-07-12 Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Country Status (1)

Country Link
TW (1) TW270112B (en)

Similar Documents

Publication Publication Date Title
EP0513387A4 (en) Active oxygen inhibitor
TR199500954A1 (en) New pyrocarbazoles.
DE69529619D1 (en) Pyrimidinylpyrazolderivate
AU6063398A (en) Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
EP0875501A3 (en) Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
BR9907191A (en) Azathricyl compounds
AU1639197A (en) Pyridine derivative, anti-ulcer drug, and antibacterial drug
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates
FI964278A0 (en) Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
ES2157679T3 (en) PROCEDURE TO PREPARE A 2-CYANOBIFENYL COMPOUND.
IL131380A0 (en) The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
AU3932297A (en) N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
TWI256383B (en) Anthraquinone compound
AU2494400A (en) New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
EP0806422A3 (en) Anti-cataract agent
CA2172946A1 (en) N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate